Fluorine in PDB 5ew3: Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Enzymatic activity of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
All present enzymatic activity of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993:
2.7.10.1;
Protein crystallography data
The structure of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993, PDB code: 5ew3
was solved by
W.Stark,
A.Goepfert,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.68 /
2.50
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
67.500,
55.760,
89.760,
90.00,
92.28,
90.00
|
R / Rfree (%)
|
21.8 /
25.4
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
(pdb code 5ew3). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993, PDB code: 5ew3:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 1 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1201
b:46.0
occ:1.00
|
F25
|
A:5T21201
|
0.0
|
46.0
|
1.0
|
C24
|
A:5T21201
|
1.4
|
43.0
|
1.0
|
F26
|
A:5T21201
|
2.2
|
47.0
|
1.0
|
F27
|
A:5T21201
|
2.2
|
40.9
|
1.0
|
C13
|
A:5T21201
|
2.4
|
41.2
|
1.0
|
C14
|
A:5T21201
|
2.8
|
40.8
|
1.0
|
CD1
|
A:LEU1019
|
3.6
|
43.5
|
1.0
|
C12
|
A:5T21201
|
3.7
|
41.6
|
1.0
|
CD2
|
A:LEU1019
|
3.7
|
44.0
|
1.0
|
CD1
|
A:ILE892
|
3.8
|
63.1
|
1.0
|
CD2
|
A:HIS1026
|
4.2
|
46.0
|
1.0
|
C15
|
A:5T21201
|
4.2
|
39.7
|
1.0
|
CG
|
A:LEU1019
|
4.3
|
43.7
|
1.0
|
CG1
|
A:VAL898
|
4.3
|
44.6
|
1.0
|
NE2
|
A:HIS1026
|
4.5
|
45.7
|
1.0
|
CG2
|
A:ILE1044
|
4.8
|
36.8
|
1.0
|
C11
|
A:5T21201
|
4.8
|
40.0
|
1.0
|
O
|
A:HOH1302
|
4.9
|
49.2
|
1.0
|
O
|
A:ILE1044
|
5.0
|
38.0
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 2 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1201
b:47.0
occ:1.00
|
F26
|
A:5T21201
|
0.0
|
47.0
|
1.0
|
C24
|
A:5T21201
|
1.3
|
43.0
|
1.0
|
F25
|
A:5T21201
|
2.2
|
46.0
|
1.0
|
F27
|
A:5T21201
|
2.2
|
40.9
|
1.0
|
C13
|
A:5T21201
|
2.3
|
41.2
|
1.0
|
C12
|
A:5T21201
|
3.1
|
41.6
|
1.0
|
NE2
|
A:HIS1026
|
3.2
|
45.7
|
1.0
|
C14
|
A:5T21201
|
3.2
|
40.8
|
1.0
|
C
|
A:CYS1045
|
3.2
|
39.1
|
1.0
|
O
|
A:CYS1045
|
3.3
|
37.9
|
1.0
|
CA
|
A:CYS1045
|
3.4
|
36.5
|
1.0
|
CD2
|
A:HIS1026
|
3.4
|
46.0
|
1.0
|
N
|
A:CYS1045
|
3.5
|
36.0
|
1.0
|
CG2
|
A:ILE1044
|
3.6
|
36.8
|
1.0
|
C
|
A:ILE1044
|
3.7
|
38.9
|
1.0
|
O
|
A:ILE1044
|
3.7
|
38.0
|
1.0
|
N
|
A:ASP1046
|
3.8
|
35.8
|
1.0
|
CB
|
A:ASP1046
|
4.3
|
38.6
|
1.0
|
C11
|
A:5T21201
|
4.3
|
40.0
|
1.0
|
CE1
|
A:HIS1026
|
4.4
|
45.3
|
1.0
|
CB
|
A:ILE1044
|
4.4
|
37.2
|
1.0
|
C15
|
A:5T21201
|
4.4
|
39.7
|
1.0
|
CA
|
A:ASP1046
|
4.6
|
36.5
|
1.0
|
CA
|
A:ILE1044
|
4.6
|
34.6
|
1.0
|
CD1
|
A:LEU1019
|
4.7
|
43.5
|
1.0
|
CG
|
A:HIS1026
|
4.7
|
44.9
|
1.0
|
CB
|
A:CYS1045
|
4.8
|
37.5
|
1.0
|
C16
|
A:5T21201
|
4.9
|
39.6
|
1.0
|
O10
|
A:5T21201
|
5.0
|
42.4
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 3 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1201
b:40.9
occ:1.00
|
F27
|
A:5T21201
|
0.0
|
40.9
|
1.0
|
C24
|
A:5T21201
|
1.3
|
43.0
|
1.0
|
F26
|
A:5T21201
|
2.2
|
47.0
|
1.0
|
F25
|
A:5T21201
|
2.2
|
46.0
|
1.0
|
C13
|
A:5T21201
|
2.3
|
41.2
|
1.0
|
C12
|
A:5T21201
|
2.8
|
41.6
|
1.0
|
CG1
|
A:VAL898
|
3.3
|
44.6
|
1.0
|
O
|
A:ILE1044
|
3.4
|
38.0
|
1.0
|
C14
|
A:5T21201
|
3.6
|
40.8
|
1.0
|
CG1
|
A:VAL899
|
3.8
|
50.6
|
1.0
|
C
|
A:ILE1044
|
4.0
|
38.9
|
1.0
|
CA
|
A:CYS1045
|
4.1
|
36.5
|
1.0
|
C11
|
A:5T21201
|
4.1
|
40.0
|
1.0
|
N
|
A:VAL899
|
4.3
|
45.9
|
1.0
|
CD2
|
A:LEU889
|
4.3
|
51.1
|
1.0
|
N
|
A:CYS1045
|
4.4
|
36.0
|
1.0
|
O
|
A:VAL899
|
4.5
|
51.1
|
1.0
|
C
|
A:CYS1045
|
4.6
|
39.1
|
1.0
|
CB
|
A:VAL898
|
4.7
|
45.4
|
1.0
|
CD1
|
A:ILE892
|
4.7
|
63.1
|
1.0
|
C15
|
A:5T21201
|
4.7
|
39.7
|
1.0
|
CG2
|
A:ILE1044
|
4.8
|
36.8
|
1.0
|
CB
|
A:VAL899
|
4.9
|
51.0
|
1.0
|
O10
|
A:5T21201
|
4.9
|
42.4
|
1.0
|
CA
|
A:VAL898
|
4.9
|
42.0
|
1.0
|
C16
|
A:5T21201
|
4.9
|
39.6
|
1.0
|
CD2
|
A:LEU1019
|
5.0
|
44.0
|
1.0
|
N
|
A:ASP1046
|
5.0
|
35.8
|
1.0
|
CA
|
A:VAL899
|
5.0
|
46.5
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 4 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1201
b:55.4
occ:1.00
|
F25
|
B:5T21201
|
0.0
|
55.4
|
1.0
|
C24
|
B:5T21201
|
1.4
|
55.6
|
1.0
|
F27
|
B:5T21201
|
2.2
|
55.7
|
1.0
|
F26
|
B:5T21201
|
2.2
|
54.7
|
1.0
|
C13
|
B:5T21201
|
2.4
|
57.3
|
1.0
|
C14
|
B:5T21201
|
2.9
|
59.0
|
1.0
|
CD1
|
B:ILE892
|
3.5
|
69.0
|
1.0
|
CD2
|
B:LEU1019
|
3.5
|
61.1
|
1.0
|
C12
|
B:5T21201
|
3.6
|
57.0
|
1.0
|
CD1
|
B:LEU1019
|
3.8
|
60.6
|
1.0
|
CG1
|
B:VAL898
|
3.9
|
47.9
|
1.0
|
CG
|
B:LEU1019
|
4.3
|
59.7
|
1.0
|
C15
|
B:5T21201
|
4.3
|
59.9
|
1.0
|
CG1
|
B:ILE892
|
4.7
|
65.4
|
1.0
|
CD2
|
B:HIS1026
|
4.7
|
74.2
|
1.0
|
C11
|
B:5T21201
|
4.8
|
57.0
|
1.0
|
O
|
B:ILE1044
|
4.9
|
51.9
|
1.0
|
CD2
|
B:LEU889
|
4.9
|
61.9
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 5 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1201
b:54.7
occ:1.00
|
F26
|
B:5T21201
|
0.0
|
54.7
|
1.0
|
C24
|
B:5T21201
|
1.4
|
55.6
|
1.0
|
F25
|
B:5T21201
|
2.2
|
55.4
|
1.0
|
F27
|
B:5T21201
|
2.2
|
55.7
|
1.0
|
C13
|
B:5T21201
|
2.3
|
57.3
|
1.0
|
C14
|
B:5T21201
|
3.1
|
59.0
|
1.0
|
NE2
|
B:HIS1026
|
3.2
|
73.9
|
1.0
|
C12
|
B:5T21201
|
3.3
|
57.0
|
1.0
|
CD2
|
B:HIS1026
|
3.4
|
74.2
|
1.0
|
C
|
B:CYS1045
|
3.5
|
54.6
|
1.0
|
CG2
|
B:ILE1044
|
3.6
|
51.4
|
1.0
|
O
|
B:CYS1045
|
3.6
|
52.6
|
1.0
|
CA
|
B:CYS1045
|
3.6
|
51.7
|
1.0
|
N
|
B:CYS1045
|
3.7
|
51.5
|
1.0
|
O
|
B:ILE1044
|
3.8
|
51.9
|
1.0
|
C
|
B:ILE1044
|
3.8
|
53.0
|
1.0
|
N
|
B:ASP1046
|
4.1
|
52.8
|
1.0
|
CB
|
B:ILE1044
|
4.4
|
50.9
|
1.0
|
CD1
|
B:LEU1019
|
4.4
|
60.6
|
1.0
|
C15
|
B:5T21201
|
4.4
|
59.9
|
1.0
|
CE1
|
B:HIS1026
|
4.5
|
73.6
|
1.0
|
C11
|
B:5T21201
|
4.5
|
57.0
|
1.0
|
CB
|
B:ASP1046
|
4.5
|
56.0
|
1.0
|
CG
|
B:HIS1026
|
4.6
|
72.9
|
1.0
|
CA
|
B:ILE1044
|
4.7
|
47.9
|
1.0
|
CG1
|
B:VAL898
|
4.8
|
47.9
|
1.0
|
CA
|
B:ASP1046
|
4.9
|
53.9
|
1.0
|
C16
|
B:5T21201
|
4.9
|
59.0
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 5ew3
Go back to
Fluorine Binding Sites List in 5ew3
Fluorine binding site 6 out
of 6 in the Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain in Complex with AAL993 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1201
b:55.7
occ:1.00
|
F27
|
B:5T21201
|
0.0
|
55.7
|
1.0
|
C24
|
B:5T21201
|
1.4
|
55.6
|
1.0
|
F25
|
B:5T21201
|
2.2
|
55.4
|
1.0
|
F26
|
B:5T21201
|
2.2
|
54.7
|
1.0
|
C13
|
B:5T21201
|
2.4
|
57.3
|
1.0
|
C12
|
B:5T21201
|
2.7
|
57.0
|
1.0
|
O
|
B:ILE1044
|
3.2
|
51.9
|
1.0
|
CG1
|
B:VAL898
|
3.4
|
47.9
|
1.0
|
CG2
|
B:VAL899
|
3.5
|
52.2
|
1.0
|
C14
|
B:5T21201
|
3.7
|
59.0
|
1.0
|
C
|
B:ILE1044
|
3.9
|
53.0
|
1.0
|
CA
|
B:CYS1045
|
4.0
|
51.7
|
1.0
|
C11
|
B:5T21201
|
4.1
|
57.0
|
1.0
|
N
|
B:VAL899
|
4.1
|
47.2
|
1.0
|
N
|
B:CYS1045
|
4.3
|
51.5
|
1.0
|
CD2
|
B:LEU889
|
4.3
|
61.9
|
1.0
|
O
|
B:VAL899
|
4.4
|
51.5
|
1.0
|
C
|
B:CYS1045
|
4.5
|
54.6
|
1.0
|
O10
|
B:5T21201
|
4.6
|
54.5
|
1.0
|
CB
|
B:VAL898
|
4.7
|
48.1
|
1.0
|
CB
|
B:VAL899
|
4.7
|
52.5
|
1.0
|
CA
|
B:VAL899
|
4.8
|
47.9
|
1.0
|
C15
|
B:5T21201
|
4.8
|
59.9
|
1.0
|
N
|
B:ASP1046
|
4.9
|
52.8
|
1.0
|
CD1
|
B:ILE892
|
4.9
|
69.0
|
1.0
|
CA
|
B:VAL898
|
4.9
|
44.5
|
1.0
|
C
|
B:VAL898
|
4.9
|
48.9
|
1.0
|
C16
|
B:5T21201
|
4.9
|
59.0
|
1.0
|
N9
|
B:5T21201
|
4.9
|
54.9
|
1.0
|
CG2
|
B:ILE1044
|
4.9
|
51.4
|
1.0
|
|
Reference:
G.Bold,
C.Schnell,
P.Furet,
P.Mcsheehy,
J.Bruggen,
J.Mestan,
P.W.Manley,
P.Druckes,
M.Burglin,
U.Durler,
J.Loretan,
R.Reuter,
M.Wartmann,
A.Theuer,
B.Bauer-Probst,
G.Martiny-Baron,
P.Allegrini,
A.Goepfert,
J.Wood,
A.Littlewood-Evans.
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth By Inhibiting Angiogenesis. J.Med.Chem. V. 59 132 2016.
ISSN: ISSN 0022-2623
PubMed: 26629594
DOI: 10.1021/ACS.JMEDCHEM.5B01582
Page generated: Thu Aug 1 09:15:12 2024
|